- Email: [email protected]
Cardiology: a call for papers
Comment
12
13
Warnecke G, Moradiellos J, Tudorache I, et al. Normothermic perfusion of donor lungs for preservation and assessment with the Organ Care System Lung before bilateral transplantation: a pilot study of 12 patients. Lancet 2012; published online Oct 10. http://dx.doi.org/10.1016/S01406736(12)61344-0. Aigner C, Slama A, Hotzenecker K, et al. Clinical ex vivo lung perfusion— pushing the limits. Am J Transplant 2012; 12: 1839–47.
14
Zych B, Popov AF, Stavri G, et al. Early outcomes of bilateral sequential single lung transplantation after ex-vivo lung evaluation and reconditioning. J Heart Lung Transplant 2012; 31: 274–81.
Cardiology: a call for papers Why not send your best cardiology papers to The Lancet? We are planning a special issue to coincide with the American College of Cardiology meeting to be held on March 9–11, 2013, in San Francisco, USA. We will consider original research papers that describe the results of randomised trials, as well as reports of other high-quality research that will influence clinical practice. Late-breaking clinical trials will be considered for fasttrack review to allow online publication immediately
after the presentation. For late-breakers the deadline for submission is Jan 21, 2013, as a fast-track submission. Please submit via our online submission system EES, stating in your covering letter that the submission is in response to this call for papers.
To submit a paper go to http:// ees.elsevier.com/thelancet
Stuart Spencer The Lancet, London NW1 7BY, UK
Regenerative medicine: a call for papers In a recent speech at the Royal Society in London, George Osborne, Britain’s Chancellor of the Exchequer, highlighted the potential of regenerative medicine to “transform current clinical approaches to replacing or regenerating damaged human organs or tissue”.1 The Lancet congratulates Osborne for throwing off the self-imposed shackles of austerity, and shares his enthusiasm for this diverse and exciting discipline.2,3 Demographic ageing of the human population will certainly lead to growth in the substantial need for replacement tissues and organs and, although not untouched by controversy, clinical research involving stem cells and other regenerative approaches is yielding promising clues as to how this need could be met. To coincide with the World Conference on Regenerative Medicine, to be held in Leipzig, Germany on Oct 23–25, 2013, The Lancet is planning a special
www.thelancet.com Vol 380 November 24, 2012
issue devoted to research in this area. We therefore invite submissions of original research in any area of regenerative medicine; we are especially interested in receiving reports of clinical trials, but other highquality research studies which have been carried out in humans and have the potential to affect clinical practice will also be welcome. Please submit through our online submission system EES by April 8, 2013, stating in your cover letter that the submission is in response to this call for papers.
To submit a paper go to http:// ees.elsevier.com/thelancet For more on the World Conference on Regenerative Medicine see http://www. wcrm-leipzig.com
Richard Turner The Lancet, London NW1 7BY, UK 1 2 3
Osborne G. Speech to the Royal Society. Nov 9, 2012. http://www. hm-treasury.gov.uk/speech_chx_091112.htm (accessed Nov 19, 2012). Ptaszek LM, Mansour M, Ruskin JN, Chien KR. Towards regenerative therapy for cardiac disease. Lancet 2012; 379: 933–42. Badylak SF, Weiss DJ, Caplan A, Macchiarini P. Engineered whole organs and complex tissues. Lancet 2012; 379: 943–52.
1801
12
13
Warnecke G, Moradiellos J, Tudorache I, et al. Normothermic perfusion of donor lungs for preservation and assessment with the Organ Care System Lung before bilateral transplantation: a pilot study of 12 patients. Lancet 2012; published online Oct 10. http://dx.doi.org/10.1016/S01406736(12)61344-0. Aigner C, Slama A, Hotzenecker K, et al. Clinical ex vivo lung perfusion— pushing the limits. Am J Transplant 2012; 12: 1839–47.
14
Zych B, Popov AF, Stavri G, et al. Early outcomes of bilateral sequential single lung transplantation after ex-vivo lung evaluation and reconditioning. J Heart Lung Transplant 2012; 31: 274–81.
Cardiology: a call for papers Why not send your best cardiology papers to The Lancet? We are planning a special issue to coincide with the American College of Cardiology meeting to be held on March 9–11, 2013, in San Francisco, USA. We will consider original research papers that describe the results of randomised trials, as well as reports of other high-quality research that will influence clinical practice. Late-breaking clinical trials will be considered for fasttrack review to allow online publication immediately
after the presentation. For late-breakers the deadline for submission is Jan 21, 2013, as a fast-track submission. Please submit via our online submission system EES, stating in your covering letter that the submission is in response to this call for papers.
To submit a paper go to http:// ees.elsevier.com/thelancet
Stuart Spencer The Lancet, London NW1 7BY, UK
Regenerative medicine: a call for papers In a recent speech at the Royal Society in London, George Osborne, Britain’s Chancellor of the Exchequer, highlighted the potential of regenerative medicine to “transform current clinical approaches to replacing or regenerating damaged human organs or tissue”.1 The Lancet congratulates Osborne for throwing off the self-imposed shackles of austerity, and shares his enthusiasm for this diverse and exciting discipline.2,3 Demographic ageing of the human population will certainly lead to growth in the substantial need for replacement tissues and organs and, although not untouched by controversy, clinical research involving stem cells and other regenerative approaches is yielding promising clues as to how this need could be met. To coincide with the World Conference on Regenerative Medicine, to be held in Leipzig, Germany on Oct 23–25, 2013, The Lancet is planning a special
www.thelancet.com Vol 380 November 24, 2012
issue devoted to research in this area. We therefore invite submissions of original research in any area of regenerative medicine; we are especially interested in receiving reports of clinical trials, but other highquality research studies which have been carried out in humans and have the potential to affect clinical practice will also be welcome. Please submit through our online submission system EES by April 8, 2013, stating in your cover letter that the submission is in response to this call for papers.
To submit a paper go to http:// ees.elsevier.com/thelancet For more on the World Conference on Regenerative Medicine see http://www. wcrm-leipzig.com
Richard Turner The Lancet, London NW1 7BY, UK 1 2 3
Osborne G. Speech to the Royal Society. Nov 9, 2012. http://www. hm-treasury.gov.uk/speech_chx_091112.htm (accessed Nov 19, 2012). Ptaszek LM, Mansour M, Ruskin JN, Chien KR. Towards regenerative therapy for cardiac disease. Lancet 2012; 379: 933–42. Badylak SF, Weiss DJ, Caplan A, Macchiarini P. Engineered whole organs and complex tissues. Lancet 2012; 379: 943–52.
1801